Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin has shown efficacy against the hepatitis C virus (HCV) in...

全面介紹

Saved in:

書目詳細資料
Main Authors:	Jordan J. Feld, Kris V. Kowdley, Eoin Coakley, Samuel H. Sigal, David R. Nelson, Dorothy H. Crawford, Ola Weiland, Humberto Aguilar, Junyuan Xiong, Edward Tam, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki, Barry Bernstein
格式:	Artigo
語言:	英语
出版:	2014
在線閱讀:	https://doi.org/10.1056/nejmoa1315722 https://www.nejm.org/doi/pdf/10.1056/NEJMoa1315722?articleTools=true
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

因特網

https://doi.org/10.1056/nejmoa1315722
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1315722?articleTools=true

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

因特網

相似書籍